Document Detail


Taxanes for Breast Cancer During Pregnancy: A Systematic Review.
MedLine Citation:
PMID:  23122538     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Landmark studies have established taxanes in the treatment of patients with breast cancer; however, recommendations regarding their administration during pregnancy are controversial. The present systematic review aims to synthesize all available data that stem exclusively from breast cancer case series to evaluate the efficacy and safety of taxanes during pregnancy. Overall, 16 studies (50 pregnancies) were eligible for the systematic review according to prisma guidelines. The mean age of patients with breast cancer at pregnancy was 34.6 years. The gestational age (GA) at chemotherapy administration varied from 12 to 36 weeks. The mean GA at delivery was 35.9 weeks. The mean weight of babies at delivery was 2380 g. In 76.7% of cases, a completely healthy neonate was born; in the remaining cases, a neonate who was dystrophic and premature, one with mild hydrocephalus, one with signs of bacterial sepsis, one with hyperbilirubinemia, one with apnea of prematurity, respiratory distress syndrome and gastroesophageal reflux, one with meconium-stained fluid, and another neonate with neutropenia and pyloric stenosis were reported. Ninety percent of children were completely healthy, with a median follow-up of 16 months; in the remaining cases, one child with recurrent otitis media, one with immunoglobulin A deficiency and mild constipation, and another child with delayed speech were reported. In conclusion, available data suggest that taxanes may potentially play a promising role in the optimal therapeutic strategy of patients with breast cancer diagnosed during pregnancy.
Authors:
Flora Zagouri; Theodoros N Sergentanis; Dimosthenis Chrysikos; Constantine Dimitrakakis; Alexandra Tsigginou; Constantine G Zografos; Meletios-Athanassios Dimopoulos; Christos A Papadimitriou
Related Documents :
21075368 - Physician experience in performing embryo transfers may affect outcome.
21272988 - Serum total ige level during pregnancy and postpartum.
7707188 - Attachment site specificity and the tapeworm assemblage in the spiral intestine of the ...
18329768 - Perfluorinated and chlorinated pollutants as predictors of demographic parameters in an...
20966468 - Collaborative study on 4-dimensional echocardiography for the diagnosis of fetal heart ...
21242588 - Pregnancy-associated breast cancer is as chemosensitive as non-pregnancy-associated bre...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-1
Journal Detail:
Title:  Clinical breast cancer     Volume:  -     ISSN:  1938-0666     ISO Abbreviation:  Clin. Breast Cancer     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-5     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100898731     Medline TA:  Clin Breast Cancer     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Elsevier Inc. All rights reserved.
Affiliation:
Department of Clinical Therapeutics, Alexandra Hospital, University of Athens, Greece. Electronic address: florazagouri@yahoo.co.uk.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Expression of underglycosylated MUC1 antigen in cancerous and adjacent normal breast tissues.
Next Document:  Should the ketogenic diet be considered for enhancing fertility?